Brain+ A/S (CPH:BRAINP)
Denmark
· Delayed Price · Currency is DKK 0.0098
-0.0006 (-5.77%)
At close: Dec 5, 2025
Brain+ Revenue
Brain+ had revenue of -515.01K DKK in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 5.80M. In the year 2024, Brain+ had annual revenue of 7.86M with 28.08% growth.
Revenue (ttm)
5.80M
Revenue Growth
+28.08%
P/S Ratio
1.92
Revenue / Employee
482.99K
Employees
12
Market Cap
11.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.86M | 1.72M | 28.08% |
| Dec 31, 2023 | 6.14M | 51.21K | 0.84% |
| Dec 31, 2018 | 6.08M | 1.74M | 40.10% |
| Dec 31, 2017 | 4.34M | 2.37M | 120.05% |
| Dec 31, 2016 | 1.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 315.60B |
| Coloplast | 27.87B |
| Genmab | 24.48B |
| ALK-Abelló | 6.08B |
| Demant | 22.59B |
| H. Lundbeck | 24.08B |
| Zealand Pharma | 9.16B |
| Ambu A/S | 6.04B |